TWD 40.6
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 223.43 Million | 749.02 Million | 380.69 Million | 135.78 Million | - |
Net Income | -916.49 Million | 724.41 Million | 289.58 Million | 74.85 Million | - |
Depreciation & Amortization | 147.18 Million | 161.04 Million | 137.47 Million | 129.29 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 1.11 Million | - | - | - | - |
Change in working capital | -189.28 Million | -93.43 Million | -36.05 Million | -72.11 Million | - |
Other non-cash items | 1.32 Billion | 3.25 Million | 4.4 Million | 4.2 Million | - |
Investing Cash Flow | -697.28 Million | -220.97 Million | -176.83 Million | -260.55 Million | - |
Investments in PPE | -364.5 Million | -218.55 Million | -171.83 Million | -259.3 Million | - |
Acquisitions | - | - | - | - | - |
Investment purchases | -343.69 Million | -3.08 Million | -5.04 Million | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 30 Thousand | -1.8 Million | - | -1.45 Million | 3.2 Million |
Financing Cash Flow | 182.47 Million | 65.39 Million | -136.83 Million | 178.93 Million | - |
Debt repayment | -506.16 Million | -203.91 Million | -86.59 Million | -251.43 Million | - |
Dividends payments | -311.16 Million | -127.47 Million | -40.79 Million | -66.28 Million | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -12.51 Million | - | - | - | - |
Accounts receivables | 484.69 Million | - | - | - | - |
Accounts payables | -362.78 Million | - | - | - | - |
Inventory | 126.34 Million | -324.13 Million | -39.73 Million | -56.29 Million | - |
Other working capital | -800.32 Million | - | - | - | - |
Cash at beginning of period | 725.15 Million | 131.7 Million | 64.68 Million | 10.52 Million | - |
Cash at end of period | 433.78 Million | 725.15 Million | 131.7 Million | 64.68 Million | - |
Capital Expenditure | -364.5 Million | -218.55 Million | -171.83 Million | -259.3 Million | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -291.37 Million | 593.45 Million | 67.02 Million | 54.16 Million | - |
Free Cash Flow | -141.07 Million | 530.47 Million | 208.85 Million | -123.52 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 288.64 Million | -52.07 Million | -248.92 Million | -916.49 Million | -1.07 Billion | 206.78 Million |
Depreciation & Amortization | 22.91 Million | 21.52 Million | 20.97 Million | 147.18 Million | 42.94 Million | 42.17 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | 1.11 Million | - | - |
Change in working capital | -79.73 Million | -133.75 Million | 56.47 Million | -189.28 Million | -82.47 Million | 203.13 Million |
Other non-cash items | 452 Thousand | -5.25 Million | -974 Thousand | 1.32 Billion | 1.33 Billion | 184 Thousand |
Investing Cash Flow | 71.93 Million | 18.5 Million | -236.51 Million | -697.28 Million | -310.02 Million | -60.9 Million |
Investments in PPE | 18.66 Million | -184.33 Million | -154.14 Million | -364.5 Million | -61.65 Million | -64.9 Million |
Acquisitions | 5.28 Million | - | - | - | - | - |
Investment purchases | - | - | -87.93 Million | -343.69 Million | -248.61 Million | 1.38 Million |
Sales/Maturities of investments | 46.84 Million | 87.1 Million | - | - | - | - |
Other Investing Activities | -1000.00 | -15.96 Million | - | 30 Thousand | - | - |
Financing Cash Flow | -353.74 Million | -185.83 Million | 424.31 Million | 182.47 Million | -35.13 Million | -357.75 Million |
Debt repayment | -351.55 Million | -182.44 Million | -429.55 Million | -506.16 Million | -32.8 Million | -44.03 Million |
Dividends payments | - | - | - | -311.16 Million | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -188.54 Million | - | - | - | - | - |
Accounts receivables | -109.23 Million | - | - | - | - | - |
Accounts payables | 65.9 Million | - | - | - | - | - |
Inventory | 16.91 Million | -37.68 Million | 20.1 Million | 126.34 Million | 44.91 Million | 134.77 Million |
Other working capital | -53.3 Million | - | - | - | - | - |
Cash at beginning of period | 96.26 Million | 433.78 Million | 418.75 Million | 725.15 Million | 546.55 Million | 661.7 Million |
Cash at end of period | 43.74 Million | 96.26 Million | 433.78 Million | 433.78 Million | 418.75 Million | 546.55 Million |
Capital Expenditure | 18.66 Million | -184.33 Million | -154.14 Million | -364.5 Million | -61.65 Million | -64.9 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -52.52 Million | -337.52 Million | 15.03 Million | -291.37 Million | -127.8 Million | -115.14 Million |
Free Cash Flow | 247.96 Million | -354.51 Million | -326.9 Million | -141.07 Million | 155.7 Million | 238.61 Million |
CEG
BODALCHEM
1272
6116
COH
UGRO